Prophylactic neuroprotection against stroke: Low-dose, prolonged treatment with deferoxamine or deferasirox establishes prolonged neuroprotection independent of HIF-1 function

Mitochondrial autophagy: Life and breath of the cell

(2014) Gregg L. Semenza   Autophagy

HIF Prolyl Hydroxylase Inhibitors Prevent Neuronal Death Induced by Mitochondrial Toxins: Therapeutic Implications for Huntington's Disease and Alzheimer's Disease

(2009) Zoya Niatsetskaya et al.   ANTIOXIDANTS & REDOX SIGNALING

Selective Inhibition of Hypoxia-Inducible Factor (HIF) Prolyl-Hydroxylase 1 Mediates Neuroprotection against Normoxic Oxidative Death via HIF- and CREB-Independent Pathways

(2009) A. Siddiq et al.   JOURNAL OF NEUROSCIENCE

Long-term efficacy and safety of deferasirox

(2008) Maria Domenica Cappellini   BLOOD REVIEWS

Pharmacokinetics, Distribution, Metabolism, and Excretion of Deferasirox and Its Iron Complex in Rats

(2008) G. J. M. Bruin et al.   DRUG METABOLISM AND DISPOSITION

Deferroxamine Preconditioning Promotes Long-Lasting Retinal Ischemic Tolerance

(2008) Yanli Zhu et al.   JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study

(2008) Hans-Christoph Diener et al.   LANCET NEUROLOGY